Hemoglobin compositions
AssigneeProlong Pharmaceuticals, LLC
InventorsAbraham ABUCHOWSKI, Glenn Kazo, Friedericke Kazo, Ronald G. Jubin
Life of this patent
Estimating the term…
Loading patent…
AssigneeProlong Pharmaceuticals, LLC
InventorsAbraham ABUCHOWSKI, Glenn Kazo, Friedericke Kazo, Ronald G. Jubin
Estimating the term…
The invention provides compositions containing hemoglobin, particularly PEGylated hemoglobin. The PEGylated hemoglobin molecule is capable of transferring oxygen or carbon monoxide bound thereto to a tissue or red blood cells with which it is in proximity. Exemplary PEGylated hemoglobin formulations of the invention are virally inactivated. Various compositions of the invention include hemoglobin, which may be conjugated with one or more water-soluble polymer. PEGylated hemoglobin includes those species in which the iron atom of the hemoglobin molecule is not bound to oxygen or any other species, and hemoglobin molecules in which a species other than oxygen, e.g., carbon monoxide, is bound to the iron atom. The compositions of the invention are formulated as hypo-, iso- or hypertonic solutions of the PEGylated hemoglobin. The compositions are of use to treat and/or ameliorate disease, injury and insult by providing for the oxygenation of tissues and/organs.
A method of treating a condition that can be ameliorated by oxygenating the red blood cells of a patient in need of such treatment, by administering to said patient a therapeutically effective amount of a PEGylated hemoglobin (PEG-Hb) conjugate wherein the hemoglobin has an average P50 of from about 7 mm Hg to about 16 mm Hg, and wherein at least 95% of said conjugate is in the form of PEGylated carboxyhemoglobin (PEG-COHb), thereby treating said condition.
Dependencies are inferred from the claim text.